Hamlin Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Hamlin Capital Management's MRK Position: Q2 2017 in Review
Hamlin Capital Management sold out of Merck (MRK) in Q2 2017, closing a stake of 815,039 shares — an estimated $49.4M sold.
Hamlin Capital Management first reported a position in MRK in Q2 2013 and held it in 16 quarters. The position peaked at $66.4M in Q2 2016. 1,925 funds tracked by Wall St. Rank hold MRK as of Q2 2017.
- Hamlin Capital Management reported no remaining Merck position as of Q2 2017 after selling out during the quarter.
- Hamlin Capital Management sold 815,039 Merck shares in Q2 2017, an estimated $49.4M.
- Hamlin Capital Management first reported a position in Merck in Q2 2013 and held it in 16 quarters.
- Hamlin Capital Management's Merck position peaked at $66.4M in Q2 2016.
- 1,925 funds tracked by Wall St. Rank held Merck as of Q2 2017.
Based on Hamlin Capital Management's 13F filing for Q2 2017, filed 27 Jul 2017.